Bis(2-aryl-5-pyridyl) derivatives

Details Bis(2-aryl-5-pyridyl) derivatives Bis(2-aryl-5-pyridyl) derivatives

2005-05-10

2005-05-10

Coleman, Brenda (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S264000

Reexamination Certificate

active

06890940

ABSTRACT:
A bis(2-aryl-5-pyridyl) compound having formula (1) or a salt thereof:wherein A is a substituted or unsubstituted aromatic hydrocarbon group, and X is a substituent having one of the following formulas (2) to (4):wherein, in formula (2), R1is a hydrogen atom or a di(lower alkyl)amino(lower alkyl) group, and m is an integer of 1 or 2; in formula (3), Y1and Y2each is a nitrogen atom or a CH group, and n is 0 or an integer of 1 to 6; in formula (4), R2and R3each is a hydrogen atom or a lower alkyl group, Z represents a single bond, a substituted methylene group, a substituted imino group, an oxygen atom or a cycloalkylene group, and p and q each is 0 or an integer of 1 to 6.

REFERENCES:
patent: 0 787 491 (1997-08-01), None
patent: 59-167564 (1984-09-01), None
patent: 1-106818 (1989-04-01), None
patent: 7-017506 (1995-03-01), None
patent: 8-092216 (1996-04-01), None
patent: 8-109177 (1996-04-01), None
patent: 10-324631 (1998-12-01), None
patent: 11-269192 (1999-10-01), None
patent: WO 9611682 (1996-04-01), None
patent: WO 9804508 (1998-02-01), None
patent: WO 9807702 (1998-02-01), None
patent: WO 9816497 (1998-04-01), None
patent: WO 9919291 (1999-04-01), None
patent: WO 9935140 (1999-07-01), None
patent: WO 9938829 (1999-08-01), None
patent: WO 9942446 (1999-08-01), None
patent: WO 0005198 (2000-02-01), None
Robert B. Fick, Jr., Current Opinion in Pulmonary Medicine, vol. 5, pp. 76-80, “Anti-IgE as Novel Therapy for the Treatment of Asthma”, 1999.
Farhad Imani, Emerging Therapeutic Targets, vol. 3, No. 2, pp. 229-240, “Emerging Therapeutic Targets in Asthma and Allergy: Modulation of IgE”, 1999.
Naosuke Matsuura, et al., Jpn. Pahrmacol. Ther., vol. 22, No. 3, pp. 1369-1383, “An Immunopharmacological Study of (±) —[2- [- (3-Ethoxy-2-Hydroxypropoxy) Phenylcarbamoyl] Ethyl] Dimethylsulfonium p-Toluenesulfonate (Suplatast Tosilate, IPD-1151T)”, 1994.
Henry Milgrom, et al., The New England Journal of Medicine, vol. 341, No. 26, pp. 1966-1973, “Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody”, Dec. 23, 1999.

Affiliated with

Also associated with

Rating

Bis(2-aryl-5-pyridyl) derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bis(2-aryl-5-pyridyl) derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bis(2-aryl-5-pyridyl) derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3426121